Neutralization serotypes of human immunodeficiency virus type 1 field isolates are not predicted by genetic subtype. The WHO Network for HIV Isolation and Characterization.

Por Weber, J, Fenyö, E M, Beddows, S, Kaleebu, P, Björndal, A
Publicado em 1996

Helminths and HIV infection: epidemiological observations on immunological hypotheses

Por BROWN, M, MAWA, P A, KALEEBU, P, ELLIOTT, A M
Publicado em 2006

Personal barriers to antiretroviral therapy adherence: case studies from a rural Uganda prospective clinical cohort

Por Mayanja, BN, Kabunga, E, Masiira, B, Lubega, R, Kaleebu, P, Seeley, J
Publicado em 2013

The Medical Research Council (UK)/Uganda Virus Research Institute Uganda Research Unit on AIDS – ‘25 years of research through partnerships’

Por Kaleebu, P, Kamali, A, Seeley, J, Elliott, A M, Katongole-Mbidde, E
Publicado no Trop Med Int Health (2015)

P16-16. Gag and Nef specific T-cell responses in HIV-1 infected long-term non-progressors in Uganda

Por Kaleebu P, Todd J, Miiro G, Pala P, Kyosiimire-Lugemwa J, Imami N, Gotch F
Publicado em 2009-10-01

P16-16. Gag and Nef specific T-cell responses in HIV-1 infected long-term non-progressors in Uganda

Por Kyosiimire-Lugemwa, J, Pala, P, Miiro, G, Todd, J, Kaleebu, P, Imami, N, Gotch, F
Publicado em 2009

P14-13. Long-term follow-up of study participants in HIV prophylactic vaccine clinical trials in Africa

Por Schmidt, C, Jaoko, W, Kaleebu, P, Karita, E, Lehrman, Allen, S, Dally, L, Smith, C, Fast, PE
Publicado em 2009

P20-10. Differences in patterns of Gag-induced immunogenetic pressure occur between clades A and D chronic HIV-1 infection in a Ugandan population

Por Serwanga, J, Ndembi, N, Nanteza, B, Mugaba, S, Pimego, E, Pala, P, Auma, B, Lyagoba, F, Kaleebu, P
Publicado em 2009

Group M consensus Gag and Nef peptides are as efficient at detecting clade A1 and D cross-subtype T-cell functions as subtype-specific consensus peptides()

Por Mugaba, S., Nakiboneka, R., Nanyonjo, M., Bugembe-Lule, D., Kaddu, I., Nanteza, B., Tweyongyere, R., Kaleebu, P., Serwanga, J.
Publicado no Vaccine (2014)

Heterogeneity of HIV incidence: a comparative analysis between fishing communities and in a neighbouring rural general population, Uganda, and implications for HIV control

Por Kamali, A, Nsubuga, R N, Ruzagira, E, Bahemuka, U, Asiki, G, Price, M A, Newton, R, Kaleebu, P, Fast, P
Publicado no Sex Transm Infect (2016)

Residual Activity of Two HIV Antiretroviral Regimens Prescribed without Virological Monitoring

Por Dunn, D. T., Goodall, R. L., Munderi, P., Kityo, C., Ranopa, M., Bacheler, L., Van Houtte, M., Gilks, C., Kaleebu, P., Pillay, D.
Publicado em 2011

P04-11. Prevalence of neutralizing antibody responses in chronic clades A and D human immunodeficiency virus type 1 (HIV-1) infections

Por Grosskurth H, Kamali A, Maher D, Levin J, Vanham G, Balla S, Montefiori D, Sokolik-Wolak B, Tomusange K, Njai HF, Pala P, Kaleebu P
Publicado em 2009-10-01

P04-11. Prevalence of neutralizing antibody responses in chronic clades A and D human immunodeficiency virus type 1 (HIV-1) infections

Por Njai, HF, Tomusange, K, Sokolik-Wolak, B, Montefiori, D, Balla, S, Vanham, G, Levin, J, Maher, D, Kamali, A, Grosskurth, H, Pala, P, Kaleebu, P
Publicado em 2009

P06-08. Building an African HIV preventive trial network

Por Price, MA, Allen, S, Anzala, O, Bekker, L, Gilmour, J, Kaleebu, P, Kamali, A, Karita, E, Lakhi, S, Latka, M, Twesigye, R, Sanders, EJ, Amornkul, P, Stevens, G, Thomson, H
Publicado em 2009

P06-06. Capacity building for HIV vaccine trials in Africa through South-South collaboration

Por Mpendo, J, Mwapasa, V, Kamali, A, Seeley, J, Birungi, J, Njai, H, Ssemaganda, A, de Bont, J, Mebrahtu, T, Nanvubya, A, Asiki, G, Kintu, E, Moore, M, Kaleebu, P
Publicado em 2009

Virological findings from the SARA trial: boosted PI monotherapy as maintenance second-line ART in Africa

Por Pillay, D, Goodall, R, Gilks, CF, Yirrell, D, Gibb, D, Spyer, M, Kaleebu, P, Munderi, P, Kityo, C, McCormick, A, Nkalubo, J, Lyagoba, F, Chirara, M, Hakim, J
Publicado em 2010

Field Study of Dried Blood Spot Specimens for HIV-1 Drug Resistance Genotyping

Por Parry, C. M., Parkin, N., Diallo, K., Mwebaza, S., Batamwita, R., DeVos, J., Bbosa, N., Lyagoba, F., Magambo, B., Jordan, M. R., Downing, R., Zhang, G., Kaleebu, P., Yang, C., Bertagnolio, S.
Publicado em 2014

Adenovirus-Based Vaccines: Comparison of Vectors from Three Species of Adenoviridae

Por Chen, H., Xiang, Z. Q., Li, Y., Kurupati, R. K., Jia, B., Bian, A., Zhou, D. M., Hutnick, N., Yuan, S., Gray, C., Serwanga, J., Auma, B., Kaleebu, P., Zhou, X., Betts, M. R., Ertl, H. C. J.
Publicado em 2010

A35 Viral evolution and innate immune responses during acute HIV-1 infection and their association with disease pathogenesis

Por Hassan, A.S., Hare, J., Kamini, G., Yindom, L.M., Kamali, A., Karita, E., Kilemba, W., Price, M.A., Borrow, P., Bjorkman, P., Albert, J., Kaleebu, P., Allan, S., Fast, P., Hunter, E., Gilmour, J., Ndung’u, T., Rowland-Jones, S., Sanders, E.J., Esbjornsson, J.
Publicado no Virus Evol (2017)

H3Africa multi-centre study of the prevalence and environmental and genetic determinants of type 2 diabetes in sub-Saharan Africa: study protocol

Por Ekoru, K., Young, E. H., Adebamowo, C., Balde, N., Hennig, B. J., Kaleebu, P., Kapiga, S., Levitt, N. S., Mayige, M., Mbanya, J. C., McCarthy, M. I., Nyan, O., Nyirenda, M., Oli, J., Ramaiya, K., Smeeth, L., Sobngwi, E., Rotimi, C. N., Sandhu, M. S., Motala, A. A.
Publicado no Glob Health Epidemiol Genom (2016)